Epicutaneous and / or intralymphatic immunotherapy for nasal allergy
Not Applicable
- Conditions
- Japanese cedar pollinosis
- Registration Number
- JPRN-UMIN000015278
- Lead Sponsor
- Osaka Medical College Otorhinolaryngology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
asthma under immunotherapy
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method nasal symptom score during the pollen season
- Secondary Outcome Measures
Name Time Method